欧洲的 CAR-T 细胞疗法: Access, 中心, and Patient Pathways

CAR-T cell therapy in Europe has become one of the most important developments in advanced cellular medicine. For selected patients with relapsed or refractory hematologic malignancies, CAR-T therapy may offer access to a highly specialized treatment pathway when conventional options have already been used. As interest in CAR-T treatment in 阅读更多

慢性阻塞性肺疾病 (慢性阻塞性肺病): 干细胞疗法可以帮助改善肺功能吗?

4 慢性阻塞性肺疾病 (慢性阻塞性肺病) 是一种以气流受限为特征的进行性肺部疾病, 炎, 以及肺组织的结构性损伤. 但为什么慢性阻塞性肺病会随着时间的推移而持续恶化?有没有办法超越症状控制并支持肺部修复? 🧠 慢性阻塞性肺病 (COPD) 会发生什么? 慢性阻塞性肺病 阅读更多